Gregory Scott Duncan - 05 Mar 2026 Form 4 Insider Report for Dogwood Therapeutics, Inc. (DWTX)

Reporting relationship: CHIEF EXECUTIVE OFFICER, Director
Issuer ticker: DWTX
Reported as of: 05 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Mar 2026, 16:16:38 UTC
Prior SEC filing: 27 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Greg Duncan

Key filing fact

Gregory Scott Duncan filed Form 4 for Dogwood Therapeutics, Inc. (DWTX) on 06 Mar 2026.

Key facts

This page summarizes Gregory Scott Duncan's Form 4 filing for Dogwood Therapeutics, Inc. (DWTX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 06 Mar 2026, 16:16.

Change

Previous filing in this sequence was filed on 27 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001831127 Primary reporting owner

Duncan Gregory Scott

Relationship: CHIEF EXECUTIVE OFFICER, Director
Address: C/O DOGWOOD THERAPEUTICS, INC., 44 MILTON AVENUE, ALPHARETTA
Signature: /s/ Greg Duncan
Signature date: 06 Mar 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DWTX transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +330,000
Change %
Price: $0.000000^*
Shares after: 330,000
Date: 05 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 330,000
Exercise price: $2.86
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock option vests one-third on March 5, 2027 and 1/24th monthly thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .